there is ALWAYS a "yeah, But" with Finkelstein...............never mentioned dry eye drug....only RGN 352 for heart neuro. Silent in whole PR on RGN 259, and that is key right now..
His wording also did sound or bode well for possibility of someone like NVS perhaps buying the 'whole cow".
This PR, in my view, was an important follow up to the Shareholder Letter which primarily contained information clarifying the trial results, it did not speak to where the company was "at large" and what next steps were being pursued. This was a good step IMO and an important part of a CEO's job. You have to provide some clarity and assurance that things are continuing to move forward according to some form of a larger business plan, and demonstrate that we're not just treading water. In between filings, you must have some form of communication with your current shareholders and market...... even if done within Safe Harbor.
Geezer, you are like a mad old bulldog. Who gives a #$%$? The size of the coverts pales in comparision to the millions of shares owned by JJ, McNay, Goldstein, sigma tau, the koreans. That is the vested interest that will be protected.
If you dont believe that then SELL, and do us all a favor.
JJ holds $20,000 in those convertible notes - -
2012 bought 15M, converts at $0.15
2013 bought 5M, converts at $0.06
But who is the unidentified buyer that stepped up in 2013 and 2014 and now holds $245,000. all convertible at 6 cents.
Have you not seen one of these types of PR's before? It is standard fare and little else, other than they know of no reason for decline, is ever provided. It accomplished exactly what is was supposed to do; just inform, in a legal fashion, that no bad news is being held back.
If you want more, try and read a 10Q.
""We are continuing to apply, independently and as part of a consortium, for grants from government and non-government organizations related to RGN-352, our T4 formulation for systemic administration of RGN-352 for cardiac and central nervous system indications," stated J.J. Finkelstein, RegeneRx's president and chief executive officer. ""
Chopps work has gotta be a shoe in for M/S and TBI grant money....
Of interest might be:
Released: April 18, 2016
Defense Health Program
Psychological Health and Traumatic Brain Injury (PH/TBI) Research Program
Upcoming Funding Opportunity
The FY16 Defense Appropriations Act provides $125 million (M) to the Department of Defense FY16 Psychological Health and Traumatic Brain Injury (PH/TBI) Research Program to support innovative research committed to complement and further ongoing DoD efforts to ensure the health and readiness of our military forces. As directed by the Office of the Assistant Secretary of Defense for Health Affairs, the Defense Health Agency, Research, Development and Acquisition (DHA RDA) Directorate manages the Defense Health Program (DHP) Research, Development, Test and Evaluation (RDT&E) appropriation. The managing agent for the anticipated Program Announcement/Funding Opportunity is the Congressionally Directed Medical Research Programs (CDMRP) with strategic oversight from Joint Program Committee 5 (JPC5)/Military Operational Medicine Research Program (MOMRP).
If its not over today, it will be by Tuesday's open. I have noticed that the gutless wonders tend to be slow to pick up news, so we may still have a few selling out this afternoon. The PR should go a long way to reassure longs. Also thought it was interesting that Finkelstein did not include the normal "going concern" wording. I think that in itself is a good sign.
Sentiment: Strong Buy
Stock action here was not caused by MM's, it was the result of new Rodman longs and some emotional long timers who think they can trade for pennies in the most illiquid of stocks. Its a joke when a stock has a 10 cent spread sometimes and a 5000 dollar trade can take stock down over 10 cents that anyone would have the penny mindset here. But. some longs here are their own worst enemy, and you know who you are.
Have some conviction with the valuation here based on the facts of Gtree valuatuon, Lifitegrast valuation and Visomitin valuation.
Wel, I'll give Finkel a "single' kudo for trying...this just punlishd comment. Sinilar such efforts by him are non existent.
What might imprtess the market more woudl be if they saw mgmt, the BOD and G Tre stepping in to BUY stock at 35 cents.
But FINKELSTEIN. Burn this to memory:
LUncheon in NYC, with Rodman.
You do NOT speak.
Dr' Godl stein takes over all.
Dr. Chopp comes in and gives neuro talk.
Dr. Chopp hands out a 50 pahge document of his previous successful tests & abstracts.
RGRX then givs out another 50 page handout of ALL teh heart tests.
Then comments from Ora that they CAN design phase 3 without CAE TORTURE.
SHOW how CAE day 29 wrecked TB4 and OTHER trials.
Do this you may get some buyers.
That patent is obviously very important to the present value of the JV. RGRX has no money to contiune to pursue, and GTREE is going to foot the bill for application. All parties make out; gtree, rgrx, and the JV if patent is awarded.
just traded .28... if they don't fire someone over the handling of matters here then the only logical conclusion one could possibly arrive at is that this whole charade has been carefully orchestrated since day one...I honestly do not think anyone could screw up this bad...if a deal is made at .40 don't anyone here say that I haven't told you so over 1 year ago.....jmho
we also need to find out who bought into digital aria just before the rgrx deal and also who tried to push rgn259 through the UK health system, using it in conjunction with cyclosporine (restasis)
Well that's just peachy keen...... sale of RGRX at 28 cents....even now with a 35 cent print up....our market cap of about 35 million? the trial did not flop by any means.
way to go finkel Tinkel:
"What we have here is a failure to communicate".
Warden to Paul Newman as he put him in the box..Cool Hand Luke.
is the nk trial using the cae or something similar? because I know if my eyes were injured, as soon as they started feeling better, the first thing I would do is take a hair dryer and blow hot dry air in them for an hour or so
Bo I agree with you that deep pocketed owners won't let this go belly up, but at the same time now and for the last at least 10 years they also didn't seem to care about what the share price is..they even let it run down to .0425....Remember these 2 owners have been awarded handsomely with sweat heart deals at these deflated stock prices...g-tree has taken 19% ownership at .15 and then added Canada rights for a song...DO NOT be confused here with level headed thinking when the playing field is so lopsided... the mm's/funds will over punish us if they can and management seems to have no desire to stop it...on the contrary they added fuel to the fire by telling the world we need to be patient and with no money in the bank taking the chance on CAE last day of trial...nobody in their right mind plays Russian roulette... it doesn't matter what I think, or want to believe...these events dictate to me that another deal is fourth coming again on less favorable terms for share holders
will it all shake out well in the end.... I would say yes...but the fact that management isn't sharing info with shareholders tells me that time isn't here just yet... funny how when our share price rose to .75 JJ put out press releases every week and now suppresses the news...
for the record and not to deceive...yes I sold some shares and yes I will buy some back lower if possible....
The stock is now up in total for the last 2 days, with a 3% up move yesterday on normal volume. It looks like the volume peaked on selloff at around a low of 15k with 700k of volume. In the US market, that would mark a volume reversal. In any event, GTree was hit with about a 30% loss off trial news while rgrx is off over 50%, if you consider yesterdays interday lows.
I thinks also news will have to be coming soon, as cash position can not be ignored. There are some deep pocketed owners of little rgrx who have a vested interest in keeping rgrx funded through next trial(and NK results). If you believe, as i do, that they will not allow BK and loss of rights to tb4, stock represents value again.